KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
KAMADA LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026
$7.61−0.15 (-1.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 21.7
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$180.46MFY2025, +9.9% a year since FY2015